- Filed
- Nov 15, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2021 · Nov 12, 2022 | 204.15M sh |
| Cash And Equivalents | Q3 2021 · Sep 30, 2021 | $659.64K |
| Cash And Equivalents | Q3 2021 · Dec 31, 2020 | $61.57K |
| Cash And Equivalents | Q3 2021 · Sep 30, 2020 | $13.85K |
| Cash And Equivalents | Q3 2021 · Dec 31, 2019 | $0 |
| Current Liabilities | Q3 2021 · Sep 30, 2021 | $7.69M |
| Current Liabilities | Q3 2021 · Dec 31, 2020 | $106.18M |
| Total Liabilities | Q3 2021 · Sep 30, 2021 | $7.69M |
| Total Liabilities | Q3 2021 · Dec 31, 2020 | $106.18M |
| Current Assets | Q3 2021 · Sep 30, 2021 | $852.68K |
| Current Assets | Q3 2021 · Dec 31, 2020 | $247.11K |
| Total Assets | Q3 2021 · Sep 30, 2021 | $852.68K |
| Total Assets | Q3 2021 · Dec 31, 2020 | $247.11K |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 2.5M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 1.03M sh |
| Operating Cash Flow | Q3 2021 · Sep 30, 2020 | −$295.58K |
| Stockholders Equity restated | Q3 2021 · Sep 30, 2020 | −$4.31M |
| Stockholders Equity | Q3 2021 · Jun 30, 2020 | −$4.61M |
| Stockholders Equity | Q3 2021 · Mar 31, 2020 | −$3.87M |
| Stockholders Equity | Q3 2021 · Dec 31, 2019 | −$3.76M |
| Eps Diluted restated | Q3 2021 · Sep 30, 2020 | −$0.22 |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | −$0.76 |
| Eps Basic restated | Q3 2021 · Sep 30, 2020 | $0.03 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | −$0.76 |
| Net Income | Q3 2021 · Sep 30, 2020 | $61.88K |
| Net Income | Q3 2021 · Sep 30, 2020 | −$783.93K |
| Net Income | Q3 2021 · Jun 30, 2020 | −$738.44K |
| Net Income | Q3 2021 · Mar 31, 2020 | −$107.37K |
| Operating Income | Q3 2021 · Sep 30, 2020 | −$549.83K |
| Operating Income | Q3 2021 · Sep 30, 2020 | −$684.82K |
| Revenue | Q3 2021 · Sep 30, 2020 | $0 |
| Revenue | Q3 2021 · Sep 30, 2020 | $0 |